Clinical trial

Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD

NCT02655302

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Sample collecting Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Lung function measure Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-07-04

PhaseNA

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Bacterial Infectionsunresolved

Interventions

Sample collectingOTHER

Lung function measureOTHER

Sponsors & collaborators

University Hospital, Lillelead sponsor

Mapped research locations

LilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02655302 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.